Navigation Links
Parkinson's Disease Foundation announces research awards totaling $1.2 million
Date:7/1/2010

(July 1, 2010, New York, NY) The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling $1.2 million for research projects designed to understand the cause(s) of and find a cure for Parkinson's disease (PD).

The awards will support the work of 15 leading scientists and are provided through two key PDF research programs, International Research Grants and Research Fellowship Grants. The first program seeks to fund "high-risk/high-reward" projects that may have a significant impact upon Parkinson's science; the second aims to support the projects of scientists who are in the early stages of their careers.

Stanley Fahn, M.D., PDF's Research Director, commented, "The work of this year's grantees is replete with original ideas for improving our understanding of Parkinson's disease at the most basic levels, and finding new approaches to treating it. We need to be sure that the best talent is attracted to the challenge of solving Parkinson's and helping those who live with it. Funding the promising projects of scientists and young fellows, an area in which PDF leads, is the best way to make this happen."

Among the scientists behind this year's research projects are James Maas, M.D., Ph.D., of the University of California, San Francisco and Leo J. Pallanck, Ph.D., of the University of Washington. With his fellowship, Dr. Maas will be conducting research into the role of dopamine, the neurotransmitter whose loss leads to Parkinson's symptoms. Through his studies into a process called dendritic dopamine release, he hopes to shed light on how the brain controls muscle movement and how the loss of that control develops in the course of Parkinson's.

Dr. Pallanck will use his research grant to investigate the potential of a surprising compound tobacco in saving the neurons lost in Parkinson's disease. He is searching for the exact chemical within tobacco that may protect neurons from the effects of Parkinson's. Dr. Pallanck says this discovery, "in turn, may one day lead to the identification of a potential treatment for Parkinson's."

A full list of 2011 research projects appears below and is available on the PDF website at www.pdf.org/en/results_funded. In fiscal year 2010, PDF contributed $5.5 million towards Parkinson's research programs.

2011 International Research Grants and Fellowships

Ataxin-3-Mediated Regulation of Parkin Stability and Activity
Thomas Durcan, Ph.D.
Montreal Neurological Institute, McGill University

The Role of Alpha-Synuclein in Parkinson's Disease Dementia and Dementia with Lewy Bodies
Sonia George, Ph.D.
University of Minnesota

Telomere Biology in Patients with Incident Parkinson's Disease
Tobias Kurth, M.D., Sc.D., and Robert Y.L. Zee, Ph.D., M.P.H.
Brigham and Women's Hospital

The Regulation of Somatodendritic Dopamine Release
James Maas, M.D., Ph.D.
University of California, San Francisco

Identification of Neuroprotective Factors in Tobacco
Leo J. Pallanck, Ph.D.
University of Washington

Potential Role of DJ-1 in Modulating the VHL/HIF Pathway and its Relevance to PD*
David Park, Ph.D.
University of Ottawa

Mechanism of FADD Recruitment and Activation in Mutant LRRK2-Induced Neurodegeneration*
Hardy Rideout, Ph.D.
Biomedical Research Foundation of the Academy of Athens

Correlating the Structure of Membrane-Bound Alpha-Synuclein with Function and Toxicity
Khurshida Shahidullah, Ph.D.
Weill Cornell Medical College

The Contribution of Dopaminergic System in Pathological Gambling in Parkinson's Disease*
Antonio P. Strafella, M.D., Ph.D., F.R.C.P.C.
Centre for Addiction and Mental Health
Toronto Western Hospital/Institute
University of Toronto

A Functional and Structural Neuroanatomic Analysis of Cognitive Impairment in Parkinson's Disease
Ryan Walsh, M.D., Ph.D.
University of Alabama at Birmingham

LINGO1 and LINGO2 in Parkinson's Disease*
Christian Wider, M.D., and Matthew J. Farrer, Ph.D.
CHUV Lausanne and University of British Columbia

Targeting the CMA Pathway in Cellular Models of Alpha-Synuclein-Induced Neurodegeneration
Maria Xilouri, Ph.D.
Biomedical Research Foundation of the Academy of Athens

Creating a South American Genetics Consortium on Parkinson's Disease*
Cyrus Zabetian, M.D., M.S.
VA Puget Sound Health Care System, Seattle Division
University of Washington


'/>"/>

Contact: Melissa Barry
mbarry@pdf.org
212-923-4700
Parkinson's Disease Foundation
Source:Eurekalert

Related medicine news :

1. Higher testosterone may raise risk of heart disease in elderly men
2. Parkinson's Disease Patient Tells Personal Story to Benefit PD Research; Donates Book Proceeds to PD Charities
3. Molecular signatures may aid fight against pediatric liver disease
4. Cancer drug shows promise for treating a wide range of inflammatory diseases
5. Statins May Not Be as Helpful for Those Without Heart Disease
6. Agent Orange exposure linked to Graves disease in Vietnam veterans, UB study finds
7. Mechanism that may trigger degenerative disease identified
8. Ingredient in red wine may prevent some blinding diseases
9. Novel radiotracer shines new light on the brains of Alzheimers disease patients
10. Hallmark Alzheimers disease changes found in retinas of humans and imaged in live animals
11. Antihypertensive drugs may protect against Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... West Palm Beach, Florida (PRWEB) , ... February ... ... Golf & Country Club) announced that it has been awarded the prestigious Distinguished ... of the World award program conducted by BoardRoom magazine, one of the most ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the ... monitor mounts ever. , “Our goal was to develop a product from the ... that we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. ...
(Date:2/10/2016)... ... 2016 , ... A new leadership team for Mid-South Youth Camp, operated by ... the announcement Monday night, Feb. 8, prior to the evening session of the university’s ... creator of GO! Camp, has been named director. Gayle McDonald, currently the assistant director ...
(Date:2/10/2016)... (PRWEB) , ... February 09, 2016 , ... ... sports concussion, yet the cause of injury may be one of many possible ... advanced PT Continuing Education Course , Mastering Rehab Solutions for the ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... PUNE, India , February 10, 2016 ... to a new market research report "Pharmaceutical Packaging Equipment ... Packaging, Wrapping, Labeling & Serialization), by Product Type (Tablet, ... to 2020", published by MarketsandMarkets, studies the global market during ... is expected to grow at a CAGR of 6.9% ...
(Date:2/10/2016)... February 10, 2016 ... Targeted Therapeutics and Companion Diagnostic Market to 2019 ... and Environment" research report indicates that the core ... billion by 2020 growing at a CAGR of ... diagnostics and targeted therapeutics and is dominated by ...
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
Breaking Medicine Technology: